Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Valentina Todorova

Concepts (193)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Doxorubicin
10
2024
233
4.790
Why?
Breast Neoplasms
12
2024
1174
2.410
Why?
Glutamine
10
2013
171
2.160
Why?
Antibiotics, Antineoplastic
5
2017
78
2.060
Why?
Mammary Neoplasms, Experimental
6
2011
122
1.550
Why?
Transcriptome
3
2024
315
1.390
Why?
Glutathione
9
2013
295
1.130
Why?
Heart Diseases
4
2012
206
0.990
Why?
Anthracyclines
1
2024
27
0.960
Why?
Myocardium
5
2024
436
0.940
Why?
Paraffin Embedding
1
2024
53
0.940
Why?
Formaldehyde
1
2024
52
0.930
Why?
Heart
4
2016
326
0.930
Why?
Sequence Analysis, RNA
1
2024
91
0.900
Why?
Neutrophils
1
2024
145
0.890
Why?
Carcinoma, Hepatocellular
2
2023
191
0.780
Why?
Liver Neoplasms
2
2023
326
0.720
Why?
Antineoplastic Agents, Alkylating
2
2011
74
0.690
Why?
Ventricular Function, Left
2
2017
154
0.680
Why?
Cyclophosphamide
2
2011
165
0.670
Why?
Rats
13
2024
3305
0.660
Why?
Adenocarcinoma
3
2011
396
0.640
Why?
MicroRNAs
1
2022
353
0.610
Why?
Chemokines
1
2017
77
0.600
Why?
Stroke Volume
1
2017
116
0.570
Why?
Exercise
1
2019
495
0.480
Why?
Gene Expression Profiling
2
2024
1032
0.470
Why?
Female
21
2024
26472
0.460
Why?
Antineoplastic Agents
2
2012
1171
0.430
Why?
Neoadjuvant Therapy
3
2022
114
0.390
Why?
Rats, Sprague-Dawley
7
2024
1597
0.380
Why?
Animals
13
2024
13187
0.360
Why?
Mastectomy, Segmental
2
2013
92
0.360
Why?
Middle Aged
9
2024
12069
0.350
Why?
Tamoxifen
1
2010
60
0.350
Why?
Biological Transport
1
2010
174
0.350
Why?
HSP70 Heat-Shock Proteins
1
2010
62
0.340
Why?
Rats, Inbred F344
4
2011
196
0.340
Why?
Receptors, Estrogen
1
2010
130
0.340
Why?
Cell Proliferation
2
2010
1007
0.330
Why?
Gene Expression Regulation, Neoplastic
2
2018
828
0.320
Why?
Catheter Ablation
1
2010
123
0.310
Why?
Humans
15
2024
49974
0.300
Why?
Matrix Metalloproteinase 9
2
2024
88
0.270
Why?
9,10-Dimethyl-1,2-benzanthracene
5
2008
51
0.270
Why?
Proto-Oncogene Proteins c-myc
1
2006
50
0.260
Why?
GPI-Linked Proteins
1
2024
29
0.240
Why?
Carcinogens
4
2008
199
0.240
Why?
Cell Adhesion Molecules
1
2024
88
0.240
Why?
Tumor Suppressor Protein p53
1
2006
202
0.240
Why?
Leukocytes, Mononuclear
2
2016
116
0.240
Why?
Tissue Fixation
1
2024
36
0.240
Why?
Signal Transduction
3
2018
1618
0.230
Why?
Adult
7
2024
13236
0.230
Why?
Hepatitis B virus
1
2023
27
0.220
Why?
Proto-Oncogene Proteins c-jun
1
2003
75
0.220
Why?
Antigens, CD
1
2024
219
0.220
Why?
Proto-Oncogene Proteins
1
2003
149
0.220
Why?
Phosphatidylinositol 3-Kinases
1
2003
141
0.220
Why?
Administration, Oral
4
2013
426
0.210
Why?
Cerebellum
1
2003
135
0.210
Why?
Hepatocytes
1
2023
182
0.210
Why?
Dietary Proteins
1
2004
242
0.200
Why?
DNA Copy Number Variations
1
2022
110
0.200
Why?
Aged
5
2024
9310
0.190
Why?
Schizophrenia
1
2003
256
0.190
Why?
Thrombocytopenia
2
2012
85
0.180
Why?
DNA, Neoplasm
1
2020
147
0.170
Why?
Ephrin-B2
1
2018
5
0.160
Why?
Yoga
1
2019
17
0.160
Why?
Paracrine Communication
1
2018
12
0.160
Why?
Intercellular Signaling Peptides and Proteins
1
2018
104
0.150
Why?
Exosomes
1
2018
49
0.150
Why?
Exercise Therapy
1
2019
98
0.150
Why?
Matrix Metalloproteinases
1
2017
48
0.150
Why?
Promoter Regions, Genetic
1
2020
475
0.150
Why?
Emotions
1
2019
165
0.150
Why?
Caspase 3
2
2010
97
0.150
Why?
Disease Models, Animal
3
2009
1455
0.140
Why?
Dose-Response Relationship, Drug
2
2011
1376
0.140
Why?
Random Allocation
2
2009
281
0.140
Why?
Apoptosis
3
2010
1101
0.140
Why?
Mental Health
1
2019
219
0.140
Why?
Polymorphism, Genetic
1
2017
181
0.140
Why?
Gene Regulatory Networks
1
2017
107
0.130
Why?
DNA Methylation
1
2020
548
0.130
Why?
Prospective Studies
2
2019
2364
0.130
Why?
Pilot Projects
1
2017
699
0.130
Why?
Models, Biological
1
2018
727
0.130
Why?
Polymorphism, Single Nucleotide
1
2017
485
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
989
0.120
Why?
Gene Expression Regulation
2
2012
976
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
2
2004
129
0.110
Why?
Oxidative Stress
2
2010
770
0.110
Why?
Molecular Sequence Annotation
1
2012
27
0.110
Why?
Lymphopenia
1
2012
18
0.110
Why?
Insulin-Like Growth Factor I
2
2003
137
0.110
Why?
Quality of Life
1
2019
836
0.110
Why?
Male
4
2024
25241
0.100
Why?
Radiotherapy
1
2013
128
0.100
Why?
Radiation Injuries
1
2013
113
0.100
Why?
Troponin I
1
2011
18
0.090
Why?
Amino Acid Transport System ASC
1
2010
4
0.090
Why?
Minor Histocompatibility Antigens
1
2010
17
0.090
Why?
Tumor Escape
1
2010
16
0.090
Why?
Tumor Cells, Cultured
1
2011
465
0.090
Why?
Heart Function Tests
1
2009
10
0.090
Why?
DNA Fragmentation
1
2010
55
0.090
Why?
Troponin
1
2009
13
0.090
Why?
Peroxynitrous Acid
1
2009
32
0.090
Why?
Acetylcysteine
1
2010
100
0.090
Why?
Immunomodulation
1
2010
37
0.090
Why?
Cell Count
1
2010
147
0.090
Why?
von Willebrand Factor
1
2009
42
0.090
Why?
T-Lymphocytes, Regulatory
1
2010
86
0.090
Why?
Lipid Peroxidation
1
2009
100
0.090
Why?
Enzyme Activation
1
2010
276
0.080
Why?
Killer Cells, Natural
1
2010
95
0.080
Why?
Muscle Cells
1
2009
22
0.080
Why?
Reproducibility of Results
1
2012
1193
0.080
Why?
Antigens, Neoplasm
1
2010
151
0.080
Why?
Eating
1
2009
162
0.080
Why?
Glycine
1
2009
75
0.080
Why?
Estradiol
1
2010
225
0.080
Why?
Body Weight
1
2011
513
0.080
Why?
Necrosis
1
2009
176
0.080
Why?
Cell Survival
1
2010
600
0.080
Why?
Antioxidants
1
2010
249
0.080
Why?
Mammary Neoplasms, Animal
1
2008
35
0.080
Why?
Echocardiography
1
2011
378
0.080
Why?
Ultrasonography
1
2009
436
0.070
Why?
Gene Expression
1
2010
609
0.070
Why?
Young Adult
1
2016
3958
0.070
Why?
Immunohistochemistry
1
2009
973
0.070
Why?
Cell Line, Tumor
1
2010
1403
0.070
Why?
Adolescent
1
2016
6356
0.060
Why?
bcl-2-Associated X Protein
1
2004
56
0.060
Why?
Caspases
1
2004
104
0.060
Why?
Receptors, Somatomedin
1
2003
8
0.060
Why?
Models, Animal
1
2004
233
0.060
Why?
Women's Health
1
2003
90
0.060
Why?
Proto-Oncogene Proteins c-akt
1
2003
157
0.050
Why?
Statistics, Nonparametric
1
2003
194
0.050
Why?
Chi-Square Distribution
1
2003
280
0.050
Why?
Transforming Growth Factor beta
1
2003
144
0.050
Why?
Down-Regulation
1
2003
348
0.050
Why?
Analysis of Variance
1
2003
562
0.050
Why?
Up-Regulation
1
2003
452
0.050
Why?
Dietary Supplements
1
2004
443
0.050
Why?
CpG Islands
1
2020
108
0.040
Why?
Diffusion Chambers, Culture
1
2018
7
0.040
Why?
Culture Media, Serum-Free
1
2018
15
0.040
Why?
Culture Media, Conditioned
1
2018
48
0.040
Why?
Laminin
1
2018
18
0.040
Why?
Hep G2 Cells
1
2018
36
0.040
Why?
Calcium-Binding Proteins
1
2018
54
0.040
Why?
Proteoglycans
1
2018
80
0.040
Why?
Drug Combinations
1
2018
123
0.040
Why?
Coculture Techniques
1
2018
146
0.040
Why?
Cell Death
1
2018
181
0.040
Why?
Neoplasm Proteins
1
2020
322
0.040
Why?
Adaptor Proteins, Signal Transducing
1
2018
197
0.040
Why?
Cell Movement
1
2018
247
0.040
Why?
Angiopoietin-2
1
2017
15
0.040
Why?
Angiopoietin-1
1
2017
16
0.040
Why?
Collagen
1
2018
206
0.040
Why?
Receptor, TIE-2
1
2017
16
0.040
Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
Why?
Clinical Trials, Phase II as Topic
1
2017
43
0.040
Why?
Tumor Microenvironment
1
2018
212
0.040
Why?
Gene Frequency
1
2017
94
0.040
Why?
Transcription Factors
1
2020
561
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
201
0.030
Why?
Regression Analysis
1
2017
395
0.030
Why?
Aged, 80 and over
1
2003
3129
0.030
Why?
Neovascularization, Pathologic
1
2017
161
0.030
Why?
Genotype
1
2017
537
0.030
Why?
Intestinal Mucosa
2
2008
225
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2013
63
0.030
Why?
Blood Proteins
1
2013
82
0.030
Why?
Myoglobin
1
2013
25
0.030
Why?
Diet
2
2008
566
0.020
Why?
Double-Blind Method
1
2013
681
0.020
Why?
Pyroglutamate Hydrolase
1
2008
2
0.020
Why?
gamma-Glutamyltransferase
1
2008
4
0.020
Why?
Glutamate-Cysteine Ligase
1
2008
20
0.020
Why?
Glutaminase
1
2008
19
0.020
Why?
Follow-Up Studies
1
2013
2182
0.020
Why?
Treatment Outcome
1
2017
5141
0.020
Why?
RNA, Messenger
1
2008
1105
0.010
Why?
Transforming Growth Factor beta1
1
2003
60
0.010
Why?
Arteries
1
2003
93
0.010
Why?
Breast
1
2003
85
0.010
Why?
Todorova's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description